SCHEMBL9760672

SCHEMBL9760672

CCOC(=O)C1=C(COCCCOCCCN)N(OC(=O)/C=C/C(=O)ON2C(C)=C(C(=O)OC)[C@H](c3cccc(Cl)c3Cl)C(C(=O)OCC)=C2COCCCOCCCN)C(C)=C(C(=O)OC)[C@@H]1c1cccc(Cl)c1Cl

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 5/20 0.50
CYP3A4 P08684 5/20 0.50
CYP2C19 P33261 4/20 0.50
TSHR P16473 4/20 0.50
TBXA2R P21731 3/20 0.50
ADRA1A P35348 3/20 0.50
SLC6A3 Q01959 3/20 0.50
ABCB11 O95342 3/20 0.50
CYP1A2 P05177 3/20 0.50
LMNA P02545 3/20 0.50
MAPT P10636 3/20 0.50
KDM4E B2RXH2 2/20 0.50
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
HIF1A Q16665 2/20 0.50
HSD17B10 Q99714 2/20 0.50
ABCB1 P08183 2/20 0.50
ADORA3 P0DMS8 2/20 0.50
ADRB3 P13945 2/20 0.50
OPRK1 P41145 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9759993 0.94 CYP2C9 (0.52) CYP2C9CYP3A4CYP2C19TSHRTBXA2R
SCHEMBL9761425 0.87 TBXA2R (0.59) CYP2C9CYP3A4CYP2C19TSHRTBXA2R
SCHEMBL5459829 0.87 TBXA2R (0.60) CYP2C9CYP3A4CYP2C19TSHRTBXA2R
SCHEMBL9760762 0.86 CACNA1C (0.43) CYP2C9CYP3A4CYP2C19TSHRTBXA2R
SCHEMBL9760183 0.85 TBXA2R (0.42) CYP2C9CYP3A4CYP2C19TSHRTBXA2R
SCHEMBL9761008 0.85 TBXA2R (0.39) CYP2C9CYP3A4CYP2C19TSHRTBXA2R
SCHEMBL9761327 0.84 PYGL (0.41) CYP2C9CYP3A4CYP2C19TSHRTBXA2R
SCHEMBL9760016 0.83 CACNA1C (0.37) CYP3A4TBXA2RADRA1ASLC6A3ABCB11
SCHEMBL7308054 0.83 TBXA2R (0.51) CYP2C9CYP3A4CYP2C19TSHRTBXA2R
SCHEMBL9760769 0.83 TBXA2R (0.43) CYP2C9CYP3A4CYP2C19TSHRTBXA2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5026863-A Medicinal products in racemic or enantiomorph form; calcium channel blockers. hypotensive agents, cardiovascular disorders ADIR ET COMPAGNIE (FR) 1991-06-25 US disclosed
US-4983740-A Multistep; from 2- 2-/2-chloroethoxy/ethoxy!ethanol and potassium phthalimide ADIR ET COMPAGNIE (FR) 1991-01-08 US disclosed
US-4870091-A CALCIUM CHANNEL BLOCKERS ADIR ET CIE (FR) 1989-09-26 US disclosed